Apple's Biggest Battleground for Foldable Phones Is China

Impact · against what's priced in

The iPhone Duo launch is a double-edged sword that may fail to deliver the growth acceleration the market demands. While it enters a new segment, the immediate boost to competitor demand in China undermines the critical goal of Chinese market expansion required to justify current valuation levels.

AAPL−0.20: Challenges what's priced in
The price assumes: Whether Apple can accelerate its revenue growth to the 17%+ the price requires, primarily through... Chinese market expansion
The price requires 17.3% revenue growth to be justified, but the iPhone Duo's announcement is paradoxically driving higher demand for Huawei and other Chinese foldables, threatening the market share gains needed for that acceleration.
What AAPL's price assumes · Aug 31

Apple's Biggest Battleground for Foldable Phones Is China

iphone▲400%
consumer electronics▲225%
china▲24%
AAPL
apple
foldables
huawei

Apple's Biggest Battleground for Foldable Phones Is China

What matters in this story

Xiaomi share price at risk as EV, smartphone, tablet woes mount

Apple's Biggest Battleground for Foldable Phones Is China

What matters in this story

Xiaomi share price at risk as EV, smartphone, tablet woes mount

How each ticker is affected

Connected tickers

Track these names every morning.

Micron Stock Gets Hammered Over China Fears — Jim Cramer Calls the Selloff 'Nonsense'

Is Apple Stock a Buy During the Holiday Quarter?

Dow closes 170 pts lower as chip stock sell off continues

Takeda's ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 1

Apple's Biggest Battleground for Foldable Phones Is China

What matters in this story

Next reads from the same story arc

Xiaomi share price at risk as EV, smartphone, tablet woes mount

Apple's Biggest Battleground for Foldable Phones Is China

What matters in this story

Next reads from the same story arc

Xiaomi share price at risk as EV, smartphone, tablet woes mount

How each ticker is affected

Connected tickers

Track these names every morning.

Micron Stock Gets Hammered Over China Fears — Jim Cramer Calls the Selloff 'Nonsense'

Is Apple Stock a Buy During the Holiday Quarter?

Dow closes 170 pts lower as chip stock sell off continues

Takeda's ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 1